A narrative review of real-world data on the safety of nintedanib in patients with idiopathic pulmonary fibrosis

The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).